U11/U12 snRNP Antibodies

Santa Cruz Biotechnology delivers a wide array of U11/U12 snRNP monoclonal antibodies for research in understanding RNA splicing mechanisms. U11/U12 snRNP Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA).U11 and U12 small nuclear ribonucleoproteins (snRNPs) are essential components of the spliceosome, functioning in the removal of introns from pre-mRNA. Their activity is fundamental for gene expression regulation and the production of mature mRNA, influencing numerous cellular processes and disease mechanisms. Research has shown that U11/U12 snRNP dysfunction can lead to various disorders, emphasizing their importance in molecular biology research. Understanding U11/U12 snRNP function has revealed new insights into RNA processing pathways and potential therapeutic targets. Investigating U11/U12 snRNP activity continues to uncover novel aspects of gene regulation and disease development. Recent studies have highlighted the role of U11/U12 snRNPs in developmental processes and tissue-specific gene expression patterns. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of RNA splicing mechanisms and their impact on human health.